LEADER 03583nam  22006135  450 
001 9910437988503321
005 20200630033900.0
010   $a1-283-69689-4
010   $a0-85729-991-3
024 7 $a10.1007/978-0-85729-991-8
035   $a(CKB)2670000000275576
035   $a(EBL)1030627
035   $a(OCoLC)813298570
035   $a(SSID)ssj0000795683
035   $a(PQKBManifestationID)11510561
035   $a(PQKBTitleCode)TC0000795683
035   $a(PQKBWorkID)10786787
035   $a(PQKB)10558193
035   $a(DE-He213)978-0-85729-991-8
035   $a(MiAaPQ)EBC1030627
035   $a(PPN)168288982
035   $a(EXLCZ)992670000000275576
100   $a20121009d2013      u|             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aInflammatory Breast Cancer$b[electronic resource] /$fedited by Jaime G. de la Garza-Salazar, Abelardo Meneses-Garcia, Claudia Arce-Salinas
205   $a1st ed. 2013.
210  1$aLondon :$cSpringer London :$cImprint: Springer,$d2013.
215   $a1 online resource (155 p.)
300   $aDescription based upon print version of record.
311   $a0-85729-990-5 
320   $aIncludes bibliographical references and index.
327   $a1. Introduction -- 2. Breast Cancer: Epidemiological Panorama and Opportunities for Prevention -- 3. Pathology of Inflammatory Breast Cancer -- 4. Inflammatory Breast Cancer. Clinical Presentation, Diagnosis, Staging Evaluation, Differential Diagnosis, Surgical Treatment, and Follow-up -- 5. Imaging -- 6. Chemotherapy -- 7. Radiotherapy in Inflammatory Breast Cancer -- 8. Recurrent Inflammatory Breast Carcinoma: Prevalence, Patterns of Recurrence, and Therapeutic Approach -- 9. The Molecular Biology of Inflammatory Breast Cancer -- 10. Target Therapy in Inflammatory Breast Cancer -- 11. Follow-Up In Inflammatory Breast Cancer.
330   $aInflammatory breast cancer is a rare and aggressive form of breast cancer that occurs in women of all ages, and, rarely, in men. Variable disease presentation means that this disease is often undetected and patients with this diagnosis have a poor prognosis. Inflammatory Breast Cancer brings together the existing clinical information on inflammatory breast cancer.  The content covers epidemiology, risk factors, diagnosis, histopathology and staging, therapy and management of patients with this disease. Recent advances in therapy have improved the prognosis of this type of cancer considerably, making this text a timely addition to the literature. This book is an essential tool for medical, surgical and clinical oncologists specialising in breast cancer, who will inevitably encounter this rare but pernicious disease.
606   $aOncology  
606   $aMedicine
606   $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160
606   $aBiomedicine, general$3https://scigraph.springernature.com/ontologies/product-market-codes/B0000X
615  0$aOncology  .
615  0$aMedicine.
615 14$aOncology.
615 24$aBiomedicine, general.
676   $a616.99/449
676   $a616.99449
702   $ade la Garza-Salazar$b Jaime G$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aMeneses-Garcia$b Abelardo$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aArce-Salinas$b Claudia$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910437988503321
996   $aInflammatory Breast Cancer$92257615
997   $aUNINA